STEMI patients with diabetes show higher mortality following PCI

09/23/2013 | Healio (free registration)

Diabetes patients who underwent percutaneous coronary intervention for STEMI had nearly four times the mortality rate of those without diabetes, according to results from the INFUSE-AMI trial. Researchers also found those with diabetes had more extensive left anterior descending artery disease and a higher 30-day revascularization rate compared with the nondiabetes cohort. The findings appear in the journal Catheterization and Cardiovascular Interventions.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC